Technical Analysis for ASMB - Assembly Biosciences, Inc.

Grade Last Price % Change Price Change
C 11.80 -3.04% -0.37
ASMB closed down 3.04 percent on Monday, March 18, 2024, on 31 percent of normal volume.
Earnings due: Mar 20
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish -2.07%
New Downtrend Bearish -2.07%
Down 3 Days in a Row Weakness -2.07%
Down 4 Days in a Row Weakness -2.07%
MACD Bearish Signal Line Cross Bearish -6.65%
1,2,3 Pullback Bullish Bullish Swing Setup -6.65%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -6.65%
NR7 Range Contraction -6.65%
Narrow Range Bar Range Contraction -6.65%
Down 3 Days in a Row Weakness -6.65%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 15 hours ago
Gapped Down (Full) about 15 hours ago
Down 3% about 15 hours ago
Fell Below Previous Day's Low about 15 hours ago
Down 2 % about 15 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Assembly Biosciences, Inc. Description

Assembly Biosciences, Inc. provides development and commercialization of gastrointestinal products in the United States. The company is developing two late-stage development product candidates, including VEN 307, a diltiazem cream for the relief of pain associated with anal fissures; and VEN 308, a phenylephrine gel for the treatment of fecal incontinence associated with ileal pouch anal anastomosis. It is also involved in the development of VEN 310 as a colonic delivery mechanism, which is a PH sensitive system to deliver bacteria, complex proteins, viral antigens, small molecules, and other treatments. The company was formerly known as Ventrus Biosciences Inc. and changed its name to Assembly Biosciences, Inc. in July, 2014. Assembly Biosciences, Inc. was founded in 2005 and is based in New York, New York.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Gastrointestinal Gastroenterology Digestive System Surgery Digestive System Phenylephrine Fecal Incontinence Gastrointestinal Products Large Intestine

Is ASMB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 20.04
52 Week Low 7.692
Average Volume 31,685
200-Day Moving Average 11.20
50-Day Moving Average 11.58
20-Day Moving Average 12.50
10-Day Moving Average 12.84
Average True Range 0.73
RSI (14) 40.12
ADX 35.17
+DI 16.92
-DI 22.99
Chandelier Exit (Long, 3 ATRs) 11.76
Chandelier Exit (Short, 3 ATRs) 13.19
Upper Bollinger Bands 14.12
Lower Bollinger Band 10.87
Percent B (%b) 0.29
BandWidth 25.96
MACD Line 0.23
MACD Signal Line 0.42
MACD Histogram -0.1967
Fundamentals Value
Market Cap 776.36 Million
Num Shares 65.8 Million
EPS -17.16
Price-to-Earnings (P/E) Ratio -0.69
Price-to-Sales 3.96
Price-to-Book 19.12
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.55
Resistance 3 (R3) 12.57 12.33 12.43
Resistance 2 (R2) 12.33 12.14 12.33 12.38
Resistance 1 (R1) 12.07 12.02 11.95 12.05 12.34
Pivot Point 11.83 11.83 11.78 11.83 11.83
Support 1 (S1) 11.57 11.64 11.45 11.55 11.26
Support 2 (S2) 11.33 11.52 11.33 11.22
Support 3 (S3) 11.07 11.33 11.18
Support 4 (S4) 11.05